These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 10696077)

  • 1. Peroxisome proliferator-activated receptors in the cardiovascular system.
    Bishop-Bailey D
    Br J Pharmacol; 2000 Mar; 129(5):823-34. PubMed ID: 10696077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
    Kliewer SA; Lehmann JM; Milburn MV; Willson TM
    Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
    Berger J; Wagner JA
    Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
    Bełtowski J; Wójcicka G; Jamroz A
    Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y
    Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
    Takano H; Komuro I
    J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.
    Keller JM; Collet P; Bianchi A; Huin C; Bouillaud-Kremarik P; Becuwe P; Schohn H; Domenjoud L; Dauça M
    Int J Dev Biol; 2000 Aug; 44(5):429-42. PubMed ID: 11032176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
    Guan Y; Breyer MD
    Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio).
    Ibabe A; Grabenbauer M; Baumgart E; Fahimi HD; Cajaraville MP
    Histochem Cell Biol; 2002 Sep; 118(3):231-9. PubMed ID: 12271359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors: from genes to physiology.
    Kliewer SA; Xu HE; Lambert MH; Willson TM
    Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.